Changes to Novasep Governance

AsiaNet 50873

POMPEY, France, Oct. 2, 2012 /PRN=KYODO JBN/ --

    - Roger-Marc Nicoud becomes Non-Executive Chairman of the Board

    - Patrick Glaser, Head of Novasep Synthesis, is appointed President and CEO

    Novasep, a leading provider of purification-based manufacturing solutions

for life science molecules, today announces the appointment of Roger-Marc

Nicoud, founder and CEO, as Non-Executive Chairman of the Board, effective on

October 1st, 2012.  

    Patrick Glaser, who has been in charge of the Novasep Synthesis division

since May 2010, becomes President and CEO, effective on October 1st, 2012.

    Bolstered by its new shareholder structure since the completion of its

refinancing, Novasep is now in a position to accelerate the development of its

activities in France and internationally, and to enter into a new phase of

growth and investments.

    In this regard, Novasep shareholders and Roger-Marc Nicoud have commonly

decided to bring about change in the firm's governance by appointing Patrick

Glaser, Head of the Novasep Synthesis division, as the new President and CEO,

while Roger-Marc Nicoud becomes Non-Executive Chairman of the Board.

    Roger-Marc Nicoud, founder and Non-Executive Chairman of the Board of

Novasep, said: "As the founder of Novasep and having managed the firm for over

20 years, I think it is the right time for a change in the company's

leadership. In a short period of time, our new shareholders have demonstrated

their commitment to support the growth of our business by endorsing significant

investment, so that we are in a position to take full advantage of our unique

leadership in purification technologies. I have been working with Patrick for

more than two years and during that time he has successfully grown our chemical

activities. I am happy to see him as my successor. With recent sizeable

commercial successes, committed shareholders and talented management, Novasep

is in good hands. As Non-Executive Chairman of the Board, I will work alongside

the other Board members to ensure a smooth transition. I will continue to share

my scientific expertise at Board level, in the interests of our customers,

shareholders and employees."

    Aviva Shneider, former Non-Executive Chairman of the Board of Novasep and

representative of the shareholders, declared:  "On behalf of the Board, I want

to thank Roger-Marc for the fantastic achievements of a long tenure as the

founder and CEO of Novasep. I am pleased that, as my successor as Non-Executive

Chairman of the Board, he will continue to contribute his unprecedented

experience and scientific skills for the benefit of all Novasep's stakeholders.

As the representative to the shareholders, I would also like to take this

opportunity to reaffirm our commitment to support the growth and expansion of

the company and our excitement about its capabilities and prospects."

    Thomas Devedjian, Director - Executive Board Member of Fonds Strategique

d'Investissement (FSI), declared: "We would like to thank Roger-Marc Nicoud for

his very strong involvement in the recovery of the Company through the recent

refinancing and different promising projects such as the new anti-cancer

molecules production capacities in Le Mans. We thus are very confident in the

future development of Novasep".

    About Novasep

    Novasep is a global provider of cost-effective and sustainable solutions to

produce active molecules at the required purity. Novasep's unique offering

includes process development services; purification equipment and turnkey

processes; contract manufacturing services; and complex active molecules to

serve pharmaceutical; biopharmaceutical; agrochemical; food and functional

ingredients; and white biotechnology industries.

    http://www.novasep.com

    For further information, please contact:

    Novasep

    Jean Blehaut

    Director, Innovation & Marketing

    France: +33-3-83-49-71-30

    SOURCE: Novasep